MGMT and glioblastoma: In 2008, Gorlia et al. proposed a nomogram for GBM patients who underwent either a partial or complete resection and were assigned to temozolomide and radiotherapy in the presence of a MGMT promoter methylation assessment (population 3 of the EORTC and NCIC trial 26981-22981/CE.3).